Number of cycles (nT) |
n_cycles
|
75 years |
- |
Names of health states (n) |
v_names_states
|
H, S1, S2, D |
- |
Annual discount rate for costs |
d_c
|
3% |
- |
Annual discount rate for QALYs |
d_e
|
3% |
- |
Number of PSA samples (K) |
n_sim
|
1,000 |
- |
Annual constant transition rates |
|
|
|
- Disease onset (H to S1) |
r_HS1
|
0.150 |
gamma(30, 200) |
- Recovery (S1 to H) |
r_S1H
|
0.500 |
gamma(60, 120) |
- Disease progression (S1 to S2) |
r_S1S2
|
0.105 |
gamma(84, 800) |
Annual mortality |
|
|
|
- Background mortality rate (H to D) |
r_HD
|
0.002 |
gamma(20, 10000) |
- Hazard ratio of death in S1 vs H |
hr_S1
|
3.0 |
lognormal(log(3.0), 0.01) |
- Hazard ratio of death in S2 vs H |
hr_S2
|
10.0 |
lognormal(log(10.0), 0.02) |
Annual costs |
|
|
|
- Healthy individuals |
c_H
|
$2,000 |
gamma(100.0, 20.0) |
- Sick individuals in S1 |
c_S1
|
$4,000 |
gamma(177.8, 22.5) |
- Sick individuals in S2 |
c_S2
|
$15,000 |
gamma(225.0, 66.7) |
- Dead individuals |
c_D
|
$0 |
- |
Utility weights |
|
|
|
- Healthy individuals |
u_H
|
1.00 |
beta(200, 3) |
- Sick individuals in S1 |
u_S1
|
0.75 |
beta(130, 45) |
- Sick individuals in S2 |
u_S2
|
0.50 |
beta(230, 230) |
- Dead individuals |
u_D
|
0.00 |
- |
Treatment A cost and effectiveness |
|
|
|
- Cost of treatment A, additional to state-specific health care costs |
c_trtA
|
$12,000 |
gamma(73.5, 163.3) |
- Utility for treated individuals in S1 |
u_trtA
|
0.95 |
beta(300, 15) |
Treatment B cost and effectiveness |
|
|
|
- Cost of treatment B, additional to state-specific health care costs |
c_trtB
|
$12,000 |
gamma(86.2, 150.8) |
- Reduction in rate of disease progression (S1 to S2) as hazard ratio (HR) |
hr_S1S2_trtB
|
log(0.6) |
lognormal(log(0.6), 0.02) |